{"id": "1344315727101231104", "creation": 1609344820.0, "user_id": "1247376635004936192", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 6, "reply_count": 0, "like_count": 3, "quote_count": 0}}, "text": "#Sinopharm, China Bio-Beijing Company's new #coronavirus inactivated #vaccine phase III clinical trial interim analysis data released\n\nNeutralizing antibody positive conversion rate was 99.52%, and vaccine's protective efficacy against #COVID19 was 79.34%\nhttps://t.co/88TzjYOnoJ", "first_save": 1634559108.199414, "hashtags": ["#SINOPHARM", "#CORONAVIRUS", "#VACCINE", "#COVID19"]}